We have previously reported that cerebral spectra from newborn babies have high phosphomonoester (PME) concentration (~7 m molelkg), low phosphocreatine (PCr) concentration (".I m molelkg, low PCrlPi (inorganic phosphate) ratio (%2), and intracellular pH Q 7.1. We present 31-P NMR results in: maple syrup urine disease, congenital lactic acidosis, gluconeogenic disorder, fetal alcohol syndrome, focal seizures and stroke, severe neurogenic arthrogryposis, lobar holoprosencephaly, and Group B strep meningitis.
* 1.0) which is characteristic of lactic acidosis. In t h e child with focal seizures and stroke, PCrIPi was Q 0.8 in the injured hemisphere vs Q 1.8 in the normal hemisphere.
In the baby with severe neurogenic arthrogryposis, PCr/Pi in resting muscle was Q 0.3 vs > 7.0 for normal resting muscle. While there were individual differences, the mean concentration of PCr and PME and mean pH did not differ significantly from control infants. These d a t a suggest t h a t a wide variety of neonatal neurologic syndromes may cause persistent changes in oxidative metabolites and t h a t 31-P NMR spectroscopy may yield significant information on the minimal value of PCrlPi t h a t is consistent with aerobic metabolism. ( To e v a l u a t e t h e e f f e c t of t h e o p h y l l i n e (TH) on v e n t i l a t o r y response of growing preterm i n f a n t s t o a combined i n s p i r a t o r y ( I ) and e x p i r a t o r y (E) r e s i s t i v e l o a d , 6 b a b i e s were s t u d i e d b e f o r e (Gr. I ) and d u r i n g (Gr. 11) TH therapy (mean + SEM TB l e v e l = 8 . 0 r 1.1 mg%) . Mean + SEM v a l u e s were: b i r t h w e i g h t = 1256 + 138g1r; g e s t a t i o n a l age = 30.2 + 0.8 wks; study age = 48 t 4.4 days and study weight = 1868 + 245 gm. Control d a t a i n c l u d i n g t i d a l volume (TV) , minute v e n t j l a t i o n (MV) , peak i n s p i r a t o r y flow ( c I ) , peak e x p i r a t o r y f l o w (VE), i n s p i r a t o r y t ? m e / t o t a l r e s p i r a t o r y time (TI/Tt ) r e s p i r a t o r y frequency ( f ) and esophageal p r e s s u r e (Pes) were ogk?ained b e f o r e and a f t e r a p p l i c a t i o n of I & E l o a d s (R1 = 50 R2 = 100 cm H20/L/sec) f o r 60 s e c . Mean + SEM v a l u e s i n Gr. I1
were: TV = 7.4 + 0 . 8 ml/kg, >V = 172.3 + 77.0 ml/min/kg, cI = 3.45 + .70 L/min, cE = 3.12 + .65 L/min, TI/Ttpt = 0.46, f = 72 + 5 b r e a t h s /min. Pes 8.7 f 2.7 cm H20. Application of R and R2 was assoc-1 i a t e d w i t h a s i g n i f i c a n t d e c r e a s e (p < .05) i n both VT (Gr. I: 2 5 4 and MV (Gr. I: 44%, Gr. 11: 29%). I n a d d i t i o n , i n Gr.1, 4 of 6 r e o n a t e s d i d n o t t o l e r a t e R1 and R2 and had i r r e g u l a r r e s p i r a t i o n s and pauses. Pes i n c r e a s e d s i g n i f i c a n t l y (p < .05) only i n Gr. I1 d u r i n g b0t.h R1 and R2. During t h e l o a d s , i n Gr. I1 no changes i n t r a n s c u t a n e o u s 02 and C02 t e n s i o n s were observed. These d a t a demonstrate t h a t TH therapy i s a s s o c i a t e d with inzreaser! :e?sbili?y t o g e n e r a t e h i g h e r Pes and improved load t o l e r a n c e . The normally high r e s i s t a n c e o f t h e f e t a l pulmonary c i r c u l at i o n d e c r e a s e s a c u t e l y i n response t o some pharmacologic agents and t o i n c r e a s e s i n f e t a l P02. We have previously observed adaptat i o n o f f e t a l pulmonary blood flow t o small i n c r e a s e s i n f e t a l P 0 1 . To determine i f a d a o t a t i o n a l s o occurs t o oharmacoloqic -c -. -----s t i m u l i , we i n f u s e d t h r e e known f e t a l pulmonary' v a s o d i l a t o r s , a c e t y l c h o l i n e (A) and histamine (H) i n 5 and bradykinin (B) i n 3, c h r o n i c a l l y prepared f e t a l sheep. A c u f f e l e c t r o m a g n e t i c flow probe measured blood flow t o t h e l e f t lung (QL). C a t h e t e r s i n t h e main pulmonary a r t e r y (PA) and a o r t a (AO) measured p r e s s u r e . A c a t h e t e r was a l s o placed i n t h e . l e f t pulmonary a r t e r y (LPA) f o r d i r e c t i n f u s i o n i n t o t h e l e f t lung thereby minimizing systemic To i n v e s t i g a t e t h e mechanism of e s t r o g e n enhancement o f t h e 0-adrenergic system i n f e t a l lung maturation, t h e following s t u d i e s were performed.
Pregnant New Zealand white r a b b i t s o f 26 days g e s t a t i o n were t r e a t e d w i t h 1 7 0 -e s t r a d i o l (20 ug/kg) with o r w i t h o u t a c t i n omycin D and cycloheximide (100 ug/kg) and 24 hours t h e r e a f t e r t h e f e t u s e s were d e l i v e r e d by Cesarean S e c t i o n . The newborns were d i v i d e d i n t o a group r e c e i v i n g lung lavage and another group was k i l l e d immediately by d e c a p i t a t i o n and t h e lungs removed and processed f o r t h e e s t i m a t i o n of 0-adrenergic r e c e p t o r s , CAMP and a d e n y l a t e c y c l a s e a c t i v i t i e s .
Estrogen s t i m u l a t e d t h e lecithin-sphingomyelin r a t i o , phosphat i d y 1 c h o l i n e c o n t e n t s i n lung lavage, and t h e 0-adrenergic r e c e p t o r s , cAMP and a d e n y l a t e c y c l a s e a c t i v i t i e s i n lung t i s s u e . These a c t i v i t i e s i n lung lavage and lung t i s s u e were i n h i b i t e d by actinomycin D and cycloheximide. These s t u d i e s s u g g e s t t h a t e s t r o g e n s t i m u l a t e s lung maturation by s y n t h e s i z i n g mRNA f o r 6-adrenergic r e c e p t o r s , and t h e regulat i o n occurs a t t h e c e l l u l a r l e v e l c o n t r o l l e d by t h e cAMP system. DIAPHRAGMATIC FATIGUE I N THE NEONATAL PIGLET.
736 LaFramboise, David E. Woodrum. Dept. of P e d i a t r i c s ,
Univ. of Washington, S e a t t l e , WA. We s t u d i e d n e u r a l i n p u t t o and f o r c e output of t h e diaphragm i n 7 a n e s t h e t i z e d n e o n a t a l p i g l e t s (wt. 2.45-3.06 kg, age 13-21 days) spontaneously b r e a t h i n g a g a i n s t a r e s p i r a t o r y load (13x normal pulmonary r e s i s t a n c e ) . , C o s t a l diaphragmatic EMG, t r a n sdiaphragmatic p r e s s u r e ( P d i ) , VE, T i , and Te were measured a t b a s e l i n e (BL) and during one hour of i n s p i r a t o r y loading. V (cc/min) f e l l s i g n i f i c a n t l y below BL by 5 ' (BL: 523'187, 5 ' :2F0 ?I10 p<.001) and d i d n o t change t h e r e a f t e r (60':288+139). Concomitantly, Pdi(cmH 0 ) i n c r e a s e d by 5'(BL: 7.823.2, 5':35.9 '20 p<.001) and remaingd unchanged a t 601(41+12). Despite t h e constancy of G and P d i a f t e r 5 ' , peak EMG a c t i v i t y , r a t e of . -> ~--, -T h i s f a i l u r e t o i n c r e a s e diaphragmatic f o r c e output i n t h e presence of i n c r e a s i n g n e u r a l d r i v e suggested p e r i p h e r a l f a t i g u e . T h i s was confirmed by g e n e r a t i n g force-frequency curves of t h e diaphragm v i a p h r e n i c s t i m u l a t i o n a t BL and 60' on load i n 3 p i g l e t s . We found marked d e c r e a s e s i n f o r c e output ( P d i ) on load compared t o BL throughout t h e range of f r e q u e n c i e s t e s t e d (10-100Hz, p<.05). We conclude t h a t diaphragmatic muscle f a t i g u e i s r e s p o n s i b l e f o r t h e decrease i n diaphragm e f f i c i e n c y noted duri n g r e s i s t i v e l o a d i n g i n t h e n e o n a t a l p i g l e t . '" " unattached to Mon a t time of death. , 
